Dr Anneliese Ashhurst from the Centenary Institute and the University of Sydney has talked about her exciting work on a new tuberculosis vaccine on the radio program ‘The Wire.
“Tuberculosis is a huge world-wide health problem. It’s caused by a bacteria that infects the lungs, is contagious and results in approximately 1.6 million deaths per year globally,” says Dr Ashhurst.
An early-stage synthetic vaccine which has been developed by Dr Ashhurst and a team of scientists has demonstrated its effectiveness in pre-clinical trials. Next steps will be to determine if the vaccine can be developed into a form suitable for use in humans.
Check out the interview here.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis.